Effect of High-calcium Intake on Appetite, Insulinemia and Incretins
This study has been completed.
Sponsor:
Northumbria University
Information provided by (Responsible Party):
Javier Gonzalez, Northumbria University
ClinicalTrials.gov Identifier:
NCT01682343
First received: September 6, 2012
Last updated: September 10, 2012
Last verified: September 2012
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | September 6, 2012 | ||||
| Last Updated Date | September 10, 2012 | ||||
| Start Date ICMJE | May 2012 | ||||
| Primary Completion Date | August 2012 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
Subjective appetite ratings [ Time Frame: 3 hour ] [ Designated as safety issue: No ] Subjective ratings of appetite assessed by visual analogue scales. |
||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | Complete list of historical versions of study NCT01682343 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE |
|
||||
| Original Secondary Outcome Measures ICMJE |
|
||||
| Current Other Outcome Measures ICMJE |
Total fat oxidised during 60 min of exercise (g) [ Time Frame: 1 hour ] [ Designated as safety issue: No ] Assessed by indirect calorimetry |
||||
| Original Other Outcome Measures ICMJE |
Total fat oxidised during 60 min of exercise (g) [ Time Frame: 1 h ] [ Designated as safety issue: No ] Assessed by indirect calorimetry |
||||
| Descriptive Information | |||||
| Brief Title ICMJE | Effect of High-calcium Intake on Appetite, Insulinemia and Incretins | ||||
| Official Title ICMJE | Effect of High-calcium Intake on Appetite, Insulinemia and Incretins | ||||
| Brief Summary | The purpose of this study is to investigate the appetite, insulin and incretin hormone responses to a high-calcium meal. |
||||
| Detailed Description | Participants will be provided with control and high-calcium meals. Insulin, appetite, glucagon-like peptide-1 and glucose-dependent insulinotropic peptide responses will be assessed, along with rates of substrate oxidation. |
||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Not Provided | ||||
| Study Design ICMJE | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Basic Science |
||||
| Condition ICMJE | Nutritional and Metabolic Diseases | ||||
| Intervention ICMJE | Dietary Supplement: Calcium
Milk-calcium supplement |
||||
| Study Arm (s) |
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Enrollment ICMJE | 10 | ||||
| Completion Date | August 2012 | ||||
| Primary Completion Date | August 2012 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Male | ||||
| Ages | Not Provided | ||||
| Accepts Healthy Volunteers | Yes | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | United Kingdom | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01682343 | ||||
| Other Study ID Numbers ICMJE | 32AN2 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Javier Gonzalez, Northumbria University | ||||
| Study Sponsor ICMJE | Northumbria University | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Northumbria University | ||||
| Verification Date | September 2012 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||